Umar Iqbal, MD

Heme/Onc fellow @Moffittnews, forever 🐊 via @ufimres| love all things myeloid | this account is an observation post for me and my cat.

[Umar Iqbal, MD @umarp53]

There is no worthier fight than the one against the Emperor of Maladies. It took me a decade and a village at my back to get to this point. I am beyond delighted on having matched to @MoffittNews. More than anything else, I consider this as an absolutely sacred responsibility.

[Umar Iqbal, MD @umarp53]

The micro-environment at Houston was very hostile to dysplastic myeloid clones. #soho26

[Umar Iqbal, MD @umarp53]

@drkeithsiau Not too dissimilar- Southam scandal 60s I think with HeLa cervical cancer cells : injected into skin of sick patients (grew tumors) and healthy prisoners (no tumors).

[Moffitt Hematology/Oncology Fellowship @MoffittHemOnc]

We're delighted to welcome our newest ⭐ class of hematology oncology fellows to @MoffittNews 🎉. Smiles all around as they kick off their journey with a comprehensive orientation month. We can't wait to see all they'll accomplish. Welcome to the Moffitt family!

[Umar Iqbal, MD @umarp53]

@UyanikMehmetS Unless you have a China connection. Really Tricky!

[Umar Iqbal, MD @umarp53]

Beautiful read.

[Bellevue Literary Review @BLReview]

🎉 BLR is thrilled to announce that “Two Thoracotomies” by Angela Tang-Tan has won a @PushcartPrize! Angela’s essay—from BLR Issue 49, our "Animalia" issue—parallels her experience in a research lab with a devastating overnight shift in the emergency room. https://t.co/rd7MonVrKg

[Umar Iqbal, MD @umarp53]

Our gentle giant logging off from PD duties after a decade of shepherding @MoffittNews Onc fellowship.

We crowned him as the “Greatest PD of all time!” (settled science, fact!)

As Henry Adams said - “A teacher affects eternity.” True indeed.

[Umar Iqbal, MD @umarp53]

@AliKhawajaMD @UTHimres @McGovernPulmCC Has to be some sort of record at this point. Congratulations!

[Umar Iqbal, MD @umarp53]

@CMichaelGibson I think one of the underappreciated problems is the litigious nature of work. This forces PCPs to refer everything to specialists and for them to becomes managers rather than doctors. Job satisfaction goes for a toss.

[ilyas sahin, MD @ilyassahinMD]

Another creative idea in cancer therapy lately...
A new @NatureMedicine * study transplanted CRISPR-edited donor stem cells with CD33 removed into patients with high-risk AML. Because the new marrow lacks CD33, a CD33-targeted drug (gemtuzumab) can then wipe out residual leukemia without harming the healthy donor cells.✅

All 30 patients engrafted (median 10 days). Relapse-free survival 14 months in a population where outcomes are usually much worse.

Still early and intensive, but the idea is exciting: engineering normal tissue so cancer therapy can be more selective and safer.

[Umar Iqbal, MD @umarp53]

@allisonoconn And mustard gas from WW1 as 1st chemotherapy!

[Danielle Hammond, MD @DanielleHammo20]

Sobering, beautiful narrative medicine essay in JAMA: “Time is Finite”.

[Shahid Mushtaq @ShahidInam35]

Spring in Kashmir 🌸

[Umar Iqbal, MD @umarp53]

I Had to Tell My Patient About His Cancer Every 10 Minutes https://t.co/dwrPi4g8WS via @doximity

[Umar Iqbal, MD @umarp53]

Check out this labor of love, a patient focused app for All things myeloma!

By the very patient outcome focused Dr. Neupane!

[Karun Neupane, MD @KarunNeupaneMD]

🎉My New Year gift for the myeloma community: AllThingsMyeloma™

A free, patient-friendly app, born out of my passion for myeloma & integrating AI in oncology-to help individuals with MGUS/SMM/MM (& caregivers) better understand & manage their journey.

✅iOS & Android

[Shahid Mushtaq @ShahidInam35]

Dal Lake Srinagar ❄️

[Umar Iqbal, MD @umarp53]

@FlavioRochaMD There is an easier answer to all this. Just limit it to 5 research items on your ERAS CV. You can only list or talk about those 5. That will automatically shift focus to quality. Not sure why there isn't much traction for this.

[Umar Iqbal, MD @umarp53]

@MikkaelSekeres @HumairaSarfraz2 @JCO_ASCO @TaylorGoodstein @CupitMaggie @ManuelaSpadea @ASCO @SylvesterCancer We should hand over the world to pediatric oncologists. I doubt anyone has more appreciation for life.

[Samer Al Hadidi, MD,MS,FACP @HadidiSamer]

Check our viewpoint published @JAMA_current #MedEd

Abstract Factory—Research Culture Harming Medical Education

The "abstract factory" is destroying medical education. Trainees and junior faculty compete with abstract counts instead of meaningful research. Result: inflated CVs, diluted conferences. We shouldn't celebrate this—you don't need publications to be a great doctor.

➡️https://t.co/IMBhy45L1K

@utswcancer @rajshekharucms @HiraSMian @ManniMD1 @HemOncFellows @ASCOTECAG

[Umar Iqbal, MD @umarp53]

@WilliamAird4 @WilliamAird4 was this settled Dr. Aird ? Curious

[Moffitt Cancer Center @MoffittNews]

At #ASH25: Umar Iqbal, MD (@umariqbalmed) presents early real-world data for revumenib confirming good tolerability with no adverse events leading to discontinuations. He shares that early efficacy data shows excellent activity across molecular and disease subsets.

#MoffittASH25 @ASH_hematology